170 related articles for article (PubMed ID: 18392689)
1. Immunotherapy for head and neck cancer.
Wu AA; Niparko KJ; Pai SI
J Biomed Sci; 2008 May; 15(3):275-89. PubMed ID: 18392689
[TBL] [Abstract][Full Text] [Related]
2. Neoantigens in immunotherapy and personalized vaccines: Implications for head and neck squamous cell carcinoma.
Zolkind P; Dunn GP; Lin T; Griffith M; Griffith OL; Uppaluri R
Oral Oncol; 2017 Aug; 71():169-176. PubMed ID: 27751760
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of head and neck cancer.
Resser JR; Carbone DP
Curr Opin Oncol; 1998 May; 10(3):226-32. PubMed ID: 9619359
[TBL] [Abstract][Full Text] [Related]
4. Personalized cancer vaccination in head and neck cancer.
Shibata H; Zhou L; Xu N; Egloff AM; Uppaluri R
Cancer Sci; 2021 Mar; 112(3):978-988. PubMed ID: 33368875
[TBL] [Abstract][Full Text] [Related]
5. [Immunotherapy: a new alternative treatment for head and neck squamous cell carcinoma].
Bron L; Romero P
Bull Cancer; 2007 Sep; 94(9):793-7. PubMed ID: 17878099
[TBL] [Abstract][Full Text] [Related]
6. Progress in head and neck cancer immunotherapy: can tolerance and immune suppression be reversed?
Ferris RL
ORL J Otorhinolaryngol Relat Spec; 2004; 66(6):332-40. PubMed ID: 15668533
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus.
Wang H; Zhao Q; Zhang Y; Zhang Q; Zheng Z; Liu S; Liu Z; Meng L; Xin Y; Jiang X
Front Immunol; 2021; 12():652054. PubMed ID: 34305889
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy in head and neck cancer: current practice and future possibilities.
Agada FO; Alhamarneh O; Stafford ND; Greenman J
J Laryngol Otol; 2009 Jan; 123(1):19-28. PubMed ID: 18761763
[TBL] [Abstract][Full Text] [Related]
9. Progress in Immunotherapy of Head and Neck Squamous Cell Carcinoma.
Almokadem S
Curr Mol Pharmacol; 2016; 9(3):226-230. PubMed ID: 26177644
[TBL] [Abstract][Full Text] [Related]
10. DNA-based immunotherapy for HPV-associated head and neck cancer.
Aggarwal C
Immunotherapy; 2016 Oct; 8(10):1187-92. PubMed ID: 27605067
[TBL] [Abstract][Full Text] [Related]
11. The fourth modality: immunotherapy for head and neck cancer hits pay dirt.
Bell RB
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jun; 121(6):575-7. PubMed ID: 27181440
[No Abstract] [Full Text] [Related]
12. Cancer immunotherapy using novel tumor-associated antigenic peptides identified by genome-wide cDNA microarray analyses.
Nishimura Y; Tomita Y; Yuno A; Yoshitake Y; Shinohara M
Cancer Sci; 2015 May; 106(5):505-11. PubMed ID: 25726868
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for head and neck cancer.
Davidson HC; Leibowitz MS; Lopez-Albaitero A; Ferris RL
Oral Oncol; 2009 Sep; 45(9):747-51. PubMed ID: 19442565
[TBL] [Abstract][Full Text] [Related]
14. Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinoma.
Atanackovic D; Blum I; Cao Y; Wenzel S; Bartels K; Faltz C; Hossfeld DK; Hegewisch-Becker S; Bokemeyer C; Leuwer R
Cancer Biol Ther; 2006 Sep; 5(9):1218-25. PubMed ID: 16929165
[TBL] [Abstract][Full Text] [Related]
15. Head and neck cancer immunotherapy: clinical evaluation.
Leibowitz MS; Nayak JV; Ferris RL
Curr Oncol Rep; 2008 Mar; 10(2):162-9. PubMed ID: 18377830
[TBL] [Abstract][Full Text] [Related]
16. Novel Treatment Options in Head and Neck Cancer.
Schuler PJ; Laban S; Doescher J; Bullinger L; Hoffmann TK
Oncol Res Treat; 2017; 40(6):342-346. PubMed ID: 28521322
[TBL] [Abstract][Full Text] [Related]
17. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
[TBL] [Abstract][Full Text] [Related]
18. Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma.
Moy JD; Moskovitz JM; Ferris RL
Eur J Cancer; 2017 May; 76():152-166. PubMed ID: 28324750
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of head and neck cancer using tumor antigen-specific monoclonal antibodies.
Lee SC; López-Albaitero A; Ferris RL
Curr Oncol Rep; 2009 Mar; 11(2):156-62. PubMed ID: 19216848
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of head and neck cancer.
Castro JE
Clin Otolaryngol Allied Sci; 1977 Feb; 2(1):65-75. PubMed ID: 338211
[No Abstract] [Full Text] [Related]
[Next] [New Search]
